Literature DB >> 28122307

HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.

Jiawen Xu1, Xi Zhang2, Hongliang Wang3, Shujian Ge4, Taihong Gao5, Lin Song1, Xinxing Wang6, Hui Li7, Yejun Qin8, Zhenhai Zhang9.   

Abstract

Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients. It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer. However, its exact mechanism in the progression of Hepatocellular carcinoma (HCC) remains unknown. Herein, HCRP1 expression and its clinical significance were examined in 101 HCC patients using immunohistochemistry. Cell proliferation, migration and invasion assays were conducted in HCC cell lines. EGFR activation and degradation were then observed after EGF inducing in HCRP1 knockdown HepG2 cells. In addition, we also detected whether epithelial-to-mesenchymal transition (EMT) was involved in the malignancy promoted by HCRP1. The results showed that 59 of the 101 HCC cases exhibited downregulation of HCRP1 expression (P<0.01) as compared to 30 benign liver lesions and 20 normal liver tissues, all of which showed a high level of HCRP1. HCRP1 expression was significantly related to age (P=0.017), pathological grade (P=0.003), tumor encapsulation (P=0.037), recurrence (P=0.039) and death (P=0.015), but unrelated to cirrhosis (P=0.216), tumor size (P=0.273), and distant metastasis (P=0.554). Lower HCRP1 expression was correlated with shorter RFS and OS (P<0.001), and decreased HCRP1 level is an independent prognostic marker in HCC patients (P<0.05). Overexpression of HCRP1 decreased and knockdown increased HCC cell proliferation, migration and invasion. HCRP1 depletion increased EGFR activation and inhibited EGFR degradation. EMT phenotype was promoted after HCRP1 downregulation via increase of Snail and Twist1 and activation of Akt phosphorylation in HepG2 cells. Conversely, upregulation of HCRP1 in SMMC-7721 cells led to the opposite effect. In conclusion, our study indicated that downregulation of HCRP1 is a valuable prognostic factor involved in EGFR regulation and acquisition of the mesenchymal phenotype of HCC cells.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Epidermal growth factor receptor; Epithelial-to-mesenchymal transition; Hepatocellular carcinoma; Hepatocellular carcinoma related protein 1

Mesh:

Substances:

Year:  2017        PMID: 28122307     DOI: 10.1016/j.biopha.2017.01.013

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

Review 1.  Exosomal miRNAs: novel players in viral infection.

Authors:  Javid Sadri Nahand; Maryam Mahjoubin-Tehran; Mohsen Moghoofei; Mohammad Hossein Pourhanifeh; Hamid Reza Mirzaei; Zatollah Asemi; Alireza Khatami; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2020-02-25       Impact factor: 4.778

2.  HCRP1, ID4 and Glypican-3: an optimal panel of biomarkers for diagnosis of hepatocellular carcinoma.

Authors:  Shujian Ge; Dan Wang; Beibei Lv; Shuping Yang; Chunmei Liu; Bin Xu; Chunming Zhao; Yejun Qin; Jiawen Xu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

3.  HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.

Authors:  Hao Xu; Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Yong-Xi Song; Jin-Yu Huang; Jun-Yan Zhang; Xing-Yu Liu; Jian-Hua Wu; Hui-Mian Xu
Journal:  Virchows Arch       Date:  2017-09-29       Impact factor: 4.064

4.  HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.

Authors:  Li Xiong; Shuqing Zhen; Qionghua Yu; Zuojiong Gong
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

5.  Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line.

Authors:  Yongxi Tong; Mingshan Wang; Haijun Huang; Jiajie Zhang; Yicheng Huang; Yingjun Chen; Hongying Pan
Journal:  Exp Ther Med       Date:  2019-09-19       Impact factor: 2.447

Review 6.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

7.  MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.

Authors:  Fangqiu Fu; Xuechao Wan; Dan Wang; Zhe Kong; Yalong Zhang; Wenhua Huang; Chenji Wang; Hai Wu; Yao Li
Journal:  Oncotarget       Date:  2017-12-06

8.  Systematic assessment of gene co-regulation within chromatin domains determines differentially active domains across human cancers.

Authors:  Marie Zufferey; Yuanlong Liu; Daniele Tavernari; Marco Mina; Giovanni Ciriello
Journal:  Genome Biol       Date:  2021-08-03       Impact factor: 13.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.